Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2009

01-10-2009 | Original Article

Barriers and Facilitators to Routine HIV Testing in VA Primary Care

Authors: Barbara G. Bokhour, PhD, Jeffrey L. Solomon, PhD, Herschel Knapp, PhD, Steven M. Asch, MD, Allen L. Gifford, MD

Published in: Journal of General Internal Medicine | Issue 10/2009

Login to get access

ABSTRACT

BACKGROUND

Approximately 21% of the 1.1 million HIV-infected persons in the United States are unaware of their HIV status. The Centers for Disease Control (CDC) recommend routine opt-out HIV testing for all patients aged 13–64. Yet little is known about patient and provider perspectives on routine HIV testing.

OBJECTIVE

We sought to understand patient and provider perspectives on the adoption of routine HIV testing within the US Department of Veterans Affairs.

DESIGN

We conducted four focus groups with patients and two focus groups with primary care providers to explore perceptions of, communication about, and barriers and facilitators to routine HIV testing in primary care.

PARTICIPANTS

Convenience sample of patients and primary care providers at two geographically diverse Veterans’ Affairs Medical Centers.

APPROACH

We conducted grounded thematic analyses of transcribed audio-recordings of focus groups to identify major themes, identifying similarities and differences between patient and provider perspectives.

MAIN RESULTS

Patients and providers concurred that implementation of routine HIV testing, treating HIV like other chronic diseases, and removing requirements for written informed consent and pre-test counseling were of benefit to patients and to public health. Patients, however, wished to have HIV testing routinely offered by providers so that they could decide whether or not to be tested. Veterans also stated that routinizing testing would help destigmatize HIV. Six steps to communicating about routine testing (“the 6 R’s”) were identified.

CONCLUSIONS

Patients and providers appear ready for implementation of routine HIV testing. However, providers should use patient-centered communication strategies to ease patients’ concerns about confidentiality and stigma associated with HIV disease.
Literature
1.
go back to reference Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD. Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis. 2007;45(Suppl 4):S248–54.CrossRefPubMed Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD. Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis. 2007;45(Suppl 4):S248–54.CrossRefPubMed
2.
go back to reference Owens DK, Sundaram V, Douglass LR, et al. Seroprevalence of HIV infection at VA health care systems. Med Decis Mak. 2003;23:569. Owens DK, Sundaram V, Douglass LR, et al. Seroprevalence of HIV infection at VA health care systems. Med Decis Mak. 2003;23:569.
3.
go back to reference Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570–85.CrossRefPubMed Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570–85.CrossRefPubMed
4.
go back to reference Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States–an analysis of cost-effectiveness. N Engl J Med. 2005;352(6):586–95.CrossRefPubMed Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States–an analysis of cost-effectiveness. N Engl J Med. 2005;352(6):586–95.CrossRefPubMed
5.
go back to reference Centers for Disease Control and Prevention. HIV prevalence estimates - United States, 2006. 2008;57:1073–1076. Centers for Disease Control and Prevention. HIV prevalence estimates - United States, 2006. 2008;57:1073–1076.
6.
go back to reference Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(RR-14):1–17. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(RR-14):1–17.
7.
go back to reference Qaseem A, Snow V, Shekelle P, Hopkins R, Jr., Owens DK. Screening for HIV in Health Care Settings: A Guidance Statement From the American College of Physicians and HIV Medicine Association. Ann Intern Med. 2008. Qaseem A, Snow V, Shekelle P, Hopkins R, Jr., Owens DK. Screening for HIV in Health Care Settings: A Guidance Statement From the American College of Physicians and HIV Medicine Association. Ann Intern Med. 2008.
8.
go back to reference Holtgrave D. Costs and consequences of the US Centers for Disease Control and Prevention’s recommendations for opt-out HIV testing. PLoS Med. 2007;4(6):e.CrossRef Holtgrave D. Costs and consequences of the US Centers for Disease Control and Prevention’s recommendations for opt-out HIV testing. PLoS Med. 2007;4(6):e.CrossRef
9.
go back to reference Bartlett JG, Branson BM, Fenton K, Hauschild BC, Miller V, Mayer KH. Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. Jama. 2008;300(8):945–51.CrossRefPubMed Bartlett JG, Branson BM, Fenton K, Hauschild BC, Miller V, Mayer KH. Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. Jama. 2008;300(8):945–51.CrossRefPubMed
10.
go back to reference Obermeyer CM, Osborn M. The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. Am J Public Health. 2007;97(10):1762–74.CrossRefPubMed Obermeyer CM, Osborn M. The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. Am J Public Health. 2007;97(10):1762–74.CrossRefPubMed
11.
go back to reference Millen JC, Arbelaez C, Walensky RP. Implications and impact of the new US centers for disease control and prevention HIV testing guidelines. Curr Infect Dis Rep. 2008;10(2):157–163.CrossRefPubMed Millen JC, Arbelaez C, Walensky RP. Implications and impact of the new US centers for disease control and prevention HIV testing guidelines. Curr Infect Dis Rep. 2008;10(2):157–163.CrossRefPubMed
12.
go back to reference Chesney MA, Smith AW. Critical delays in HIV testing and care - The potential role of stigma. Am Behav Sci. 1999;42(7):1162–1174.CrossRef Chesney MA, Smith AW. Critical delays in HIV testing and care - The potential role of stigma. Am Behav Sci. 1999;42(7):1162–1174.CrossRef
13.
go back to reference Epstein R, Morse D, Frankel R, Frarey L, Anderson K, Beckman H. Awkward moments in patient-physician communication about HIV risk. Ann Intern Med. 1998;128(6):435–42.PubMed Epstein R, Morse D, Frankel R, Frarey L, Anderson K, Beckman H. Awkward moments in patient-physician communication about HIV risk. Ann Intern Med. 1998;128(6):435–42.PubMed
14.
go back to reference Epstein RM, Levenkron JC, Frarey L, et al. Improving physicians’ HIV risk-assessment skills using announced and unannounced standardized patients. J Gen Intern Med. 2001;16:176–180.CrossRefPubMed Epstein RM, Levenkron JC, Frarey L, et al. Improving physicians’ HIV risk-assessment skills using announced and unannounced standardized patients. J Gen Intern Med. 2001;16:176–180.CrossRefPubMed
15.
go back to reference Rogers WH, Kazis LE, Miller DR, et al. Comparing the health status of VA and non-VA ambulatory patients: the veterans’ health and medical outcomes studies. J Ambul Care Manage. 2004;27(3):249–62.PubMed Rogers WH, Kazis LE, Miller DR, et al. Comparing the health status of VA and non-VA ambulatory patients: the veterans’ health and medical outcomes studies. J Ambul Care Manage. 2004;27(3):249–62.PubMed
16.
go back to reference Owens DK, Sundaram V, Lazzeroni LC, et al. Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV. Am J Public Health. 2007;97(12):2173–8.CrossRefPubMed Owens DK, Sundaram V, Lazzeroni LC, et al. Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV. Am J Public Health. 2007;97(12):2173–8.CrossRefPubMed
17.
go back to reference Strauss AL. Qualitative Analysis for Social Scientists. Cambridge [Cambridgeshire]; New York: Cambridge University Press; 1987. Strauss AL. Qualitative Analysis for Social Scientists. Cambridge [Cambridgeshire]; New York: Cambridge University Press; 1987.
18.
go back to reference Charmaz K. Constructing Grounded Theory. Thousand Oaks, CA: Sage; 2006. Charmaz K. Constructing Grounded Theory. Thousand Oaks, CA: Sage; 2006.
19.
go back to reference NVIVO 7.0 qualitative data software program]. Qualitative Solutions and Research, International; 2007. NVIVO 7.0 qualitative data software program]. Qualitative Solutions and Research, International; 2007.
20.
go back to reference Bayer R, Fairchild AL. Changing the paradigm for HIV testing-the end of exceptionalism. N Engl J Med. 2006;355:647–69.CrossRefPubMed Bayer R, Fairchild AL. Changing the paradigm for HIV testing-the end of exceptionalism. N Engl J Med. 2006;355:647–69.CrossRefPubMed
21.
go back to reference Anderson M, Elam G, GErvere S, Solarin I, Fenton K, Estabrook P. HIV/AIDS stigma and discrimination: Accounts of HIV-positive Carribean people in the United Kingdom. Soc Sci Med; 2008. Anderson M, Elam G, GErvere S, Solarin I, Fenton K, Estabrook P. HIV/AIDS stigma and discrimination: Accounts of HIV-positive Carribean people in the United Kingdom. Soc Sci Med; 2008.
22.
go back to reference Talley A, Bettencourt B. A relationship-oriented model of HIV-related stigma derived from a review of the HIV-affected couples literature. AIDS Behavior; 2008. Talley A, Bettencourt B. A relationship-oriented model of HIV-related stigma derived from a review of the HIV-affected couples literature. AIDS Behavior; 2008.
23.
go back to reference Meiberg A, Bos A, Onya H, Schaalma H. Fear of stigmatization as barrier to voluntary HIV counselling and testing in South Africa. East Afr Public Health. 2008;5(2):49–54. Meiberg A, Bos A, Onya H, Schaalma H. Fear of stigmatization as barrier to voluntary HIV counselling and testing in South Africa. East Afr Public Health. 2008;5(2):49–54.
24.
go back to reference Sobo E, Bowman C, Asch SA, Goetz MB, Gifford AL. “A routine thing”: Implementation of a computerized HIV test clinical reminder for veterans. Anthroplogy and Medicine. 2008;15(3):213–25. Sobo E, Bowman C, Asch SA, Goetz MB, Gifford AL. “A routine thing”: Implementation of a computerized HIV test clinical reminder for veterans. Anthroplogy and Medicine. 2008;15(3):213–25.
25.
go back to reference Burke RC, Sepkowitz KA, Bernstein KT, et al. Why don’t physicians test for HIV? A review of the US literature. Aids. 2007;21(12):1617–24.CrossRefPubMed Burke RC, Sepkowitz KA, Bernstein KT, et al. Why don’t physicians test for HIV? A review of the US literature. Aids. 2007;21(12):1617–24.CrossRefPubMed
26.
go back to reference Valdisseri R. Late HIV diagnosis: Bad medicine and worse public health. PLoS Med. 2007;4:e200.CrossRef Valdisseri R. Late HIV diagnosis: Bad medicine and worse public health. PLoS Med. 2007;4:e200.CrossRef
Metadata
Title
Barriers and Facilitators to Routine HIV Testing in VA Primary Care
Authors
Barbara G. Bokhour, PhD
Jeffrey L. Solomon, PhD
Herschel Knapp, PhD
Steven M. Asch, MD
Allen L. Gifford, MD
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 10/2009
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-1078-6

Other articles of this Issue 10/2009

Journal of General Internal Medicine 10/2009 Go to the issue

Reflection

REFLECTION

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.